Poster presented at the RCPsych International Congress 2016
Adherence to medication is a well-recognised problem in people with bipolar disorder, with over half of people reporting to not taking their medication as instructed.(1)(2) Poor or non-adherence is associated with an exacerbation of symptoms, neurocognitive decline and increased risk of suicide.(1)(3)
Mednet recently devised an evidence-based psychoeducation module to be embedded with an advanced monitored dosage system to be used to enhance medication adherence in people with bipolar disorder. The findings from which were published and presented at the Royal College of Psychiatrists International Congress 2016 in an iPoster, entitled ‘Enhancing adherence for patients with Bipolar Disorder: A phase-I feasibility study’. In addition to writing, submitting and successfully having had the poster accepted, we also created the interactive digital iPoster.
The key results presented in our poster were:
- Favourable benefit of the intervention in increasing medication adherence and patient and carer understanding of bipolar disorder.
- The psychoeducation element was reported to enhance participant knowledge and understanding of bipolar disorder.
- All participants reported a greater understanding of the importance of medication adherence coupled with excellent satisfaction in the medication management system.
- Qualitative healthcare professional and carer feedback was also very positive towards the use of the intervention.
Funding for the study was provided by The Northern Ireland Small Business Research Initiative (SBRI) grant and conducted in partnership with Protomed Limited.
1. Sajatovic, M. et al. Six-month outcomes of customized adherence enhancement (CAE) therapy in bipolar disorder. Bipolar Disord. 2012: 14; 291-300
2. Gibson, S. et al. Understanding treatment non-adherence in schizophrenia and bipolar disorder: A survey of what service users do and why. BMC Psychiatry. 2013; 13
3. Gaudiano, B. A. & Moitra, E. Leveraging mobile technology to improve the treatment of comorbid bipolar and substance use disorders. J Addict Res Ther. 2015